- 307
Surely it is NOT wrong???????
Like an agent told me the other day: "Can't you see what a mess O'Bama has made of our health system, and he's not even President yet!" I didn't answer.
Seems to me this potential implosion of Part-D drug plans would be much more important to monitor than controlling agents commissions.
Print - Reference-Based Pricing - another Part D penalty
Medicare Part D: Penalties for Brand Drugs Hidden From Beneficiaries - AARP Bulletin Today
US health plans view reference-based pricing. | Goliath Business News
"Some US health insurers are experimenting with reference-based drug pricing plans, which offer prices based on actual cost instead of tiered co-payments and rebates, reports AP.
The new schemes, being offered by insurers such as Humana and WellPoint Health Networks, typically divide into medicines categories (eg, acute care, chronic care, lifestyle and drugs to boost workplace productivity) and set an allowance for each one, based on the average or lowest price of products in the group. Patients then pay the difference between the allowance and the drug's actual cost.
Meantime, market research firm Kline & Co reports that managed care organizations and pharmacy benefit managers are considering the possibility of extending coverage to certain classes of over-the-counter drugs, particularly those recently switched from prescription status. However, while this development offers opportunities for partnerships between drugmakers and MCOs, many insurers do not want to be seen endorsing specific brands or companies, comments the report."
Like an agent told me the other day: "Can't you see what a mess O'Bama has made of our health system, and he's not even President yet!" I didn't answer.
Seems to me this potential implosion of Part-D drug plans would be much more important to monitor than controlling agents commissions.
Print - Reference-Based Pricing - another Part D penalty
Medicare Part D: Penalties for Brand Drugs Hidden From Beneficiaries - AARP Bulletin Today
US health plans view reference-based pricing. | Goliath Business News
"Some US health insurers are experimenting with reference-based drug pricing plans, which offer prices based on actual cost instead of tiered co-payments and rebates, reports AP.
The new schemes, being offered by insurers such as Humana and WellPoint Health Networks, typically divide into medicines categories (eg, acute care, chronic care, lifestyle and drugs to boost workplace productivity) and set an allowance for each one, based on the average or lowest price of products in the group. Patients then pay the difference between the allowance and the drug's actual cost.
Meantime, market research firm Kline & Co reports that managed care organizations and pharmacy benefit managers are considering the possibility of extending coverage to certain classes of over-the-counter drugs, particularly those recently switched from prescription status. However, while this development offers opportunities for partnerships between drugmakers and MCOs, many insurers do not want to be seen endorsing specific brands or companies, comments the report."
